Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ThermoDox |
| Synonyms | |
| Therapy Description |
ThermoDox is heat-sensitive, liposomal formulation of the anthracyline, doxorubicin (PMID: 31436231). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ThermoDox | Chemotherapy - Anthracycline 13 | ThermoDox is heat-sensitive, liposomal formulation of the anthracyline, doxorubicin (PMID: 31436231). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT00826085 | Phase Ib/II | ThermoDox | Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall | Completed | USA | 0 |
| NCT02536183 | Phase I | ThermoDox | A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors | Terminated | USA | 0 |